James C. Lancaster
Keine laufenden Positionen mehr
Profil
James C.
Lancaster Jr. has been Vice President of Commercial Operations for OREXIGEN Therapeutics, Inc. since August 2006.
Previously, he was a Marketing Consultant for Alkermes, Inc., G & S Research, Inc., Corcept Therapeutics, Inc., Neuronetics, Inc. and Eli Lilly and Company from March 2004 to August 2006.
Mr. Lancaster received a BS degree in Pharmacy from the University of Tennessee.
Ehemalige bekannte Positionen von James C. Lancaster
| Unternehmen | Position | Ende |
|---|---|---|
| OREXIGEN THERAPEUTICS, INC. | Corporate Officer/Principal | 10.03.2008 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01.02.2003 |
Ausbildung von James C. Lancaster
| University of Tennessee | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
